FDA ramps up its pushback against compounded GLP-1s In a move that will delight Novo Nordisk and Eli Lilly, the FDA has sent warning letters to 30 telehealth companies, accusing them of illegally marketing compounded GLP-1 agonist formulations
Collagen production naturally diminishes with age, contributing to the appearance of fine lines and wrinkles, and sagging skin
Both Eli Lilly and Novo Nordisk are working on oral GLP-1 medications, which will reportedly be available on the government-run DTC platform for $145-a-month
This multidisciplinary approach exemplifies how converging technologies can elucidate drug mechanisms in contexts relevant to human health
Peptides, or small protein fragments, are often too unstable to use as drugs, but in this study, the researchers also developed a way to stabilize the molecules and help them get into target cells
Ann Med, 26: 297-300